LON:AOR AorTech International (AOR) Share Price, News & Analysis → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free AOR Stock Alerts GBX 123.50 -3.00 (-2.37%) (As of 06/18/2020) Add Compare Share Share Today's Range 122▼ 12650-Day Range 123.50▼ 123.5052-Week Range 40.50▼ 134.70Volume7,419 shsAverage Volume40,686 shsMarket Capitalization£19.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get AorTech International alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About AorTech InternationalAorTech International plc, together with its subsidiaries, focuses on the commercialization of its biomedical polymer technology, components, and medical devices in the United Kingdom. The company offers Elast-Eon, a bio stable polyurethane material used in long term implantation; and Elast-Eon Carbonate Silicone, a family of biomedical polymers for applications in cardiac pacing leads, orthopedics, and spinal discs, as well as in other applications where the device requires a high level of mechanical performance. It also provides Elast-Eon Reaction Injection Molding products for use in high-precision medical device components. In addition, the company licenses its technology; and offers support services to other medical device companies. AorTech International plc was incorporated in 1996 and is headquartered in Weybridge, the United Kingdom.Read More AOR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AOR Stock News HeadlinesApril 24, 2023 | marketwatch.com2023-2030 Bioprosthetics Market Size with [95 Pages] includes Industry Chain Analysis | New Report by Absolute ReportsMarch 30, 2023 | marketwatch.comElectrophysiology (EP) Ablation Catheters Market by 2031March 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 20, 2023 | marketwatch.comBioprosthetics Market Major Players, Anlysis and Forecast till 2028March 4, 2023 | marketwatch.comGlobal Bioprosthetics Market 2023 Growth Opportunities, Top Players, Regions, Application, and Forecast to 2030 By VMReportsFebruary 16, 2023 | marketwatch.comMechanical Heart Valve Market Outlook 2023 and Forecast to 2028 with Top Countries DataJanuary 18, 2023 | marketwatch.comMechanical Heart Valve Market 2023 : Manufacturers Strategies, Share Estimation, Future Demand and Regional Growth Dynamics 2029September 21, 2022 | marketwatch.comPercutaneous Mitral Valve Repair Device Market 2022-2028 Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & AnalysisMarch 28, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.June 10, 2022 | marketwatch.comCardiac Valve Market-Industry Analysis, Share, Size Trends, Demand, Growth, Revenue, Top Companies and Forecasts 2022 to 2028December 16, 2021 | lse.co.ukTRADING UPDATES: Listing costs hobble Orcadian and ProCook earningsOctober 20, 2021 | ca.finance.yahoo.comGlobal Bioprosthetics Market Research Report (2021 to 2026) - by Type, Application and Region - ResearchAndMarkets.comSeptember 2, 2021 | proactiveinvestors.comRUA Life Sciences - Result of AGMAugust 31, 2021 | proactiveinvestors.comRUA Life Sciences - AGM Statement and Trading UpdateAugust 10, 2021 | proactiveinvestors.comRUA Life Sciences - Directorate ChangeSee More Headlines Receive AOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AorTech International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:AOR CUSIPN/A CIKN/A Webwww.aortech.net Phone+44-1932-252123FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio32.06 Quick Ratio32.06 Sales & Book Value Annual Sales£539,000.00 Price / Sales37.09 Cash FlowGBX 14.82 per share Price / Cash Flow8.33 Book ValueGBX 19.40 per share Price / Book6.37Miscellaneous Outstanding Shares16,186,600Free FloatN/AMarket Cap£19.99 million OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. William Donald Brown (Age 55)CEO, Exec. Chairman & Fin. Director Mr. John McKenna (Age 66)Director of Clinical Marketing & Exec. Director Mr. Ajay Padsalgikar Ph.D.Chief Scientific OfficerMr. David J. C. ParsonsCompany Sec.Key CompetitorsOxford BioDynamicsLON:OBDOptiBiotix HealthLON:OPTISkinBioTherapeuticsLON:SBTXOndine BiomedicalLON:OBIOKYO PharmaLON:OKYOView All Competitors AOR Stock Analysis - Frequently Asked Questions How have AOR shares performed in 2024? AorTech International's stock was trading at GBX 123.50 at the beginning of 2024. Since then, AOR shares have increased by 0.0% and is now trading at GBX 123.50. View the best growth stocks for 2024 here. What other stocks do shareholders of AorTech International own? Based on aggregate information from My MarketBeat watchlists, some companies that other AorTech International investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Ascential (ASCL), Empyrean Energy (EME), Lloyds Banking Group (LYG), Starbucks (SBUX), Activision Blizzard (ATVI), Alphabet (GOOG), Petropavlovsk (POG) and Scancell (SCLP). How do I buy shares of AorTech International? Shares of AOR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AOR) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AorTech International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.